Mosquito allergy can rarely give raise to severe clinical manifestations.Here we describe the case of a patient suffering from relapsing anaphylaxis after mosquito bites, who completely responded to off label therapy with anti-IgE monoclonal antibody.This is the first demonstration of the efficacy of omalizumab in such unusual life-threatening allergy.